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Fragile X-associated tremor/ataxia syndrome
(FXTAS) is an inherited neurodegenerative disorder
caused by the expansion of 55–200 CGG repeats in
the 50 UTR of FMR1. These expanded CGG repeats
are transcribed and accumulate in nuclear RNA
aggregates that sequester one or more RNA-binding
proteins, thus impairing their functions. Here, we
have identified that the double-stranded RNA-
binding protein DGCR8 binds to expanded CGG
repeats, resulting in the partial sequestration of
DGCR8 and its partner, DROSHA, within CGG RNA
aggregates. Consequently, the processing of micro-
RNAs (miRNAs) is reduced, resulting in decreased
levels of mature miRNAs in neuronal cells expressing
expanded CGG repeats and in brain tissue from
patients with FXTAS. Finally, overexpression of
DGCR8 rescues the neuronal cell death induced by
expression of expanded CGG repeats. These results
support a model in which a human neurodegenera-
tive disease originates from the alteration, in trans,
of the miRNA-processing machinery.
INTRODUCTION
Fragile X-associated tremor/ataxia syndrome (FXTAS) is a neuro-
degenerative disorder that affects older adult males who are
carriers of an expansion of 55–200 CGG repeats in the 50 UTR
of the fragile X mental retardation 1 (FMR1) gene (Hagerman
et al., 2001). The clinical features of FXTAS include progressive
intention tremor and gait ataxia, frequently accompanied by
progressive cognitive decline, parkinsonism, peripheral neurop-
athy, and autonomic dysfunctions (Jacquemont et al., 2003).
Principal neuropathology of FXTAS includes mild brain atrophyand white matter lesions with the presence of ubiquitin-positive
nuclear neuronal and astrocytic inclusions (Greco et al., 2002),
which contain the expanded CGG RNA repeats (Tassone et al.,
2004). In contrast to fragile X syndrome, where full mutations
(>200 CGG repeats) result in hypermethylation and silencing of
the FMR1 gene, FXTAS carriers of shorter CGG expansions
(55–200 CGG repeats) present increased expression of FMR1
mRNA levels and normal, or near-normal, FMRP expression
(Tassone et al., 2000). These observations suggest a toxic
RNA gain-of-function model for FXTAS. In support of that model,
cellular and transgenic Drosophila and mouse models demon-
strate that the sole expression of a mutant RNA containing
expanded CGG repeats is sufficient to induce the formation of
ubiquitin-positive aggregates and to cause a pathology similar
to human FXTAS (Willemsen et al., 2003; Jin et al., 2003; Arocena
et al., 2005; Entezam et al., 2007; Hashem et al., 2009). A toxic
RNA gain-of-function model predicts that expanded CGG
repeats are pathogenic by sequestering specific RNA-binding
proteins, resulting in loss of their normal functions and, ulti-
mately, in neuronal cell dysfunction and death. Consistent
with a titration model, various proteins were found to colocalize
with CGG or ubiquitin-positive inclusions (Iwahashi et al., 2006;
Jin et al., 2007; Sofola et al., 2007; Sellier et al., 2010); however,
the pathological consequences of their recruitment are unclear,
suggesting that the protein(s) sequestered within CGG RNA
aggregates and responsible for the neuronal cell death, remains
to be identified.
MicroRNAs (miRNAs) are small, conserved, noncoding RNAs
that are key components of posttranscriptional gene regulation
and are involved in the control of many fundamental processes,
including both differentiation and survival of neurons (Schaefer
et al., 2007; Davis et al., 2008; De Pietri Tonelli et al., 2008;
Stark et al., 2008; Haramati et al., 2010; He´bert et al., 2010;
Huang et al., 2010; Fe´nelon et al., 2011; Schofield et al., 2011).
miRNAs are initially transcribed by the RNA polymerase II as
primary miRNA (pri-miRNAs) transcripts, which are processed
into precursor miRNAs (pre-miRNAs) by the type III RNase,Cell Reports 3, 869–880, March 28, 2013 ª2013 The Authors 869
050
100
A 
130 
95 
72 
55 
36 
28 
250 
MW 
86 
79 
78 
76 
56 
46 
44 
43 
40 
GENE 
DGCR8 
MPP10 
ZCHC8 
ESRP1 
GLD2 
ZC3HA 
RBMS1 
DAZP1 
LSM11 
CGG 
 20x 
- 
- 
- 
+ 
- 
+ 
- 
+ 
+ 
CGG 
60x 
++ 
+ 
+ 
++ 
+ 
++ 
+ 
++ 
++ 
77 PRP3 + ++ 
hnRNP A2 
PUR
++ + 
++ + 
37 
35 
B C 
E 
%
 C
o-
lo
ca
liz
at
io
n 
D 
CGGDGCR8
C
TL
C
G
G
 6
0x
DGCR8
DROSHA
CTL CGG 60x 
Merged
Figure 1. Identification of Proteins Associ-
ated with Expanded CGG Repeats
(A) Silver staining of proteins extracted from
mouse brain and captured on streptavidin resin
coupled to biotinylated in-vitro-transcribed RNA
containing expanded CGG repeats of normal or
pathogenic size. MW, molecular weight.
(B) List of the main proteins identified by nanoLS-
MS/MS that are preferentially associated with 20
or 60 CGG repeats.
(C) Western blotting against DGCR8 or DROSHA
of mouse brain proteins captured on 20 or 60 CGG
RNA repeat columns.
(D) RNA FISH against CGG repeats, coupled to
IF against DGCR8, of COS7 cells transfected with
a plasmid expressing either no repeats (CTL) or
60 CGG repeats. Magnification, 6303. Scale
bars, 10 mm.
(E) Percentage of colocalization of the endoge-
nous-tested candidate proteins within CGG RNA
aggregates analyzed by RNA FISH coupled to IF
on COS7 transfected for 24 hr with a plasmid ex-
pressing either no repeats or 60 CGG repeats.
See also Tables S1, S2, and Figure S1.DROSHA, and the double-stranded RNA-binding protein,
DGCR8, which anchors DROSHA to the pri-miRNA transcript
(Lee et al., 2003; Denli et al., 2004; Landthaler et al., 2004;
Gregory et al., 2004; Han et al., 2004; Wang et al., 2007). Pre-
miRNAs are then exported into the cytoplasm, where they are
processed into mature miRNAs by the DICER enzyme. Global
reduction ofmiRNA expression, for example through inactivation
of DICER or DGCR8 in mice, results in embryonic lethality and if
conditionally lost in brain, leads to neuronal dysfunction and
cell death (Schaefer et al., 2007; Davis et al., 2008; De Pietri
Tonelli et al., 2008; Stark et al., 2008; Haramati et al., 2010;
He´bert et al., 2010; Huang et al., 2010; Fe´nelon et al., 2011;
Schofield et al., 2011).
Here, we find that DGCR8 binds preferentially to expansions of
CGG repeats of pathogenic length. This association results in
titration of DGCR8 pri-miRNA-binding activity and in the partial
sequestration of DGCR8 and its partner, DROSHA, within CGG
RNA aggregates. Consequently, the processing of pri-miRNAs
is reduced in cells expressing expanded CGG repeats, and in
brain samples from patients with FXTAS, resulting in decreased
levels of mature miRNAs. Finally, the expression of pathogenic-
expanded CGG repeats in cultured mouse cortical neurons
results in decreased dendritic complexity and reduced neuronal
cell viability. Importantly, the sole overexpression of DGCR8
restored to normal both the dendritic morphological abnormali-
ties and the loss of neuronal cells, demonstrating that titration
of DGCR8 by expanded CGG repeats is a leading event to
CGG-induced neuronal cell death.
RESULTS
Identification of Proteins Associated with Expanded
CGG Repeats
To identify proteins involved in FXTAS physiopathology, proteins
extracted frommouse brain nuclei were captured on streptavidin
resin coupled to biotinylated RNA composed of nonpathogenic870 Cell Reports 3, 869–880, March 28, 2013 ª2013 The Authors(20 CGG repeats) or pathogenic expansions (60 or 100 CGG
repeats), eluted, separated on SDS-PAGE, and identified by
nano-LC-MS/MS analysis (Figure 1A). More than 30 RNA-
binding proteins were identified (Figure 1B; Tables S1 and S2),
including hnRNP A2/B1, hnRNP G, and PURa, which were also
identified in previous studies (Iwahashi et al., 2006; Jin et al.,
2007; Sofola et al., 2007; Sellier et al., 2010). However, these
proteins were recruited preferentially onto short CGG repeats
compared to long pathogenic CGG stretches (Figure 1B). In
contrast, ten proteins (ESRP1, PRP3, ZC3HA, LSM11, ZCHC8,
MPP10, DAZP1, RBMS1, GLD2, and DGCR8) were found
preferentially associated with expanded CGG repeats of patho-
genic size (Figure 1B). We confirmed the preferential binding of
DGCR8 on long CGG stretches by western blotting on the
protein eluted from the RNA affinity columns (Figure 1C). The
partner of DGCR8, DROSHA, was also preferentially recruited
to long expanded CGG repeats (Figure 1C).
Next, to discard nonspecific RNA-binding proteins, we tested
whether these candidate proteins colocalize with the aggre-
gates formed by expanded CGG repeats in transfected COS7
cells (Figures S1A and S1B). Among the ten candidates tested,
only three (PRP3, ZC3HA, and DGCR8) colocalized with CGG
RNA aggregates (Figures 1D and S1A). However, we noted
that PRP3 and ZC3HA were naturally localized in speckles,
which are normal nuclear structures enriched in some splic-
ing factors and that were found previously to be associated
with CGG RNA aggregates in transfected cells (Sellier et al.,
2010). Thus, neither PRP3 nor ZC3HA was specifically re-
cruited within CGG RNA aggregates (Figure S1A). In con-
trast, DGCR8 presented a diffuse pattern within the nucleo-
plasm, but upon expression of 60 expanded pathogenic
CGG repeats, DGCR8 changed localization and was recruited
within CGG RNA inclusions (Figure 1D). As further controls,
we also tested the colocalization of proteins, such as hnRNP
A2/B1 and PURa, which were found mostly associated with
20 biotinylated CGG RNA repeats in vitro. Consistent with a
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Figure 2. DGCR8 and DROSHA Bind to
Expanded CGG RNA Repeats
(A) Gel shift assays of purified bacterial recombinant
His-DGCR8D with 100 nM (30,000 cpm) of
uniformly a-[32P]CTP internally labeled in-vitro-
transcribed RNA containing 20 or 100 CGG repeats
or the pri-miR-125.
(B) Quantification of DGCR8 binding to 20, 40, 60, or
100 CGG RNA repeats.
(C) RNA FISH against CGG repeats, coupled to
IF against SAM68, on COS7 cells cotransfected
with a plasmid expressing 60 CGG repeats and
a siRNA against the luciferase (siCTL) or against
DGCR8.
(D and E) RNA FISH of CGG repeats coupled to IF of
DROSHA or DGCR8 on brain sections (hippo-
campal area) of age-matched control or patients
with FXTAS. Magnification, 6303. Nuclei were
counterstained with DAPI.
(F and G) Larger fields of CGGRNA FISH coupled to
IF of DROSHA or DGCR8 on brain sections
of patients with FXTAS. White arrows indicate
CGG RNA aggregates. Note some nonspecific
perinuclear background inherent to RNA FISH of
autopsied human brain samples.
Scale bars, 10 mm.
See also Figure S2.preferential binding to normal but not to expanded CGG
repeats, we found no significant colocalization of these
candidates with CGG RNA aggregates at early time points
(Figure 1E). Thus, we pursued our study on the one proteinCell Reports 3, 869–88found specifically associated with ex-
panded CGG repeats of pathogenic
size, DGCR8.
DGCR8 Binds to Mutated RNA
Containing Expanded CGG Repeats
Recruitment of DGCR8 to biotinylated
CGG RNA questions whether DGCR8
binds directly, or through indirect pro-
tein-protein interactions, to expanded
CGG repeats. Gel shift assays showed
that purified recombinant HIS-tagged
DGCR8 protein binds directly to RNAs
containing expanded CGG repeats of
pathogenic size (60 and 100 CGG repeats;
Figures 2A, S2A, and S2B). In contrast,
DGCR8 binds weakly to RNAs containing
CGG stretch of nonpathogenic size, such
as 20 or 40 CGG repeats (Figures 2A,
S2A, and S2B). Furthermore, DGCR8
binds to expanded CGG repeats with
an affinity similar to control pri-miRNAs,
such as pri-miR-124, pri-miR-125, or
pri-Let-7 (Figures 2A and S2A). UV-cross-
linking assays confirmed that purified
recombinant DGCR8 binds directly to
control pri-miR-124 and pri-miR-125, aswell as to expanded CGG repeats of pathogenic size, but does
not bind to short CGG stretch (Figure S2B).
The in vitro binding of DGCR8 to long expanded CGG repeats
prompted us to investigate whether DROSHA and DGCR8 are0, March 28, 2013 ª2013 The Authors 871
recruited within the nuclear aggregates found in cell models of
FXTAS. CGG RNA aggregates are dynamic nuclear structures
that accumulate various proteins in a time-dependent manner
(Sellier et al., 2010), which raises the question of the timing of
DROSHA and DGCR8 recruitment. Analysis of the formation of
CGG RNA aggregates at various time points after transfection
of COS7 cells with a plasmid expressing 60 CGG repeats re-
vealed that DROSHA andDGCR8 colocalizedwithin CGGaggre-
gates from the time of their formation (6–8 hr posttransfection;
data not shown). Furthermore, depletion of either DROSHA or
DGCR8 by siRNA reduced the recruitment of SAM68, one of
the earliest proteins found to colocalize with CGG aggregates
(Figures 2C and S2C). Next, coimmunoprecipitation experiments
demonstrated that DROSHA and DGCR8 interact with SAM68,
suggesting that the recruitment of SAM68 within CGG RNA
aggregates is mediated through protein-protein interactions
with DROSHA or DGCR8 (Figure S2D). These results suggest
that in transfected cells, DROSHA and DGCR8 are among the
first proteins to be recruited within the CGG RNA aggregates
and are essential for the further aggregation of other proteins,
such as SAM68. These results were obtained in cells expressing
large amounts of expanded CGG RNA repeat. Thus, to rule out
any overexpression bias, we tested the localization of endoge-
nous DROSHA and DGCR8 in brain sections from patients with
FXTAS. RNA FISH coupled to immunofluorescence (IF) experi-
ments showed that both DROSHA and DGCR8 consistently
colocalized with endogenous CGG nuclear RNA aggregates in
brain sections of patients with FXTAS (Figures 2D and 2E; larger
fields in Figures 2F and 2G), whereas DROSHA andDGCR8were
diffusely localized within the nucleoplasm of age-matched non-
FXTAS controls. Finally, we tested the localization of endoge-
nous DROSHA, DGCR8, and CGG aggregates in brain sections
of a knockin mouse model, in which endogenous CGG repeats
had been replaced with an expansion of 98 CGG repeats (Wil-
lemsen et al., 2003). RNA FISH coupled to IF labeling showed
the presence of rare nuclear CGG RNA aggregates that colocal-
ized with both endogenous DROSHA and DGCR8 in mice
expressing expanded CGG repeats (Figures S2E and S2F). By
contrast, DROSHA and DGCR8 were diffuse throughout the
nucleoplasm in control mice.We noted that theCGGRNA aggre-
gates were larger and much more frequent in patients with
FXTAS than in knockin mice, which is consistent with the milder
neurological disturbances observed in knockin mice compared
to patients with FXTAS (Willemsen et al., 2003).
The direct binding of DGCR8 to expanded CGG trinucleotide
repeats raises the question as to how specific this interaction
is and, notably, whether DGCR8 can also recognize other trinu-
cleotide repeats such as expanded CUG repeats, the mutation
responsible of myotonic dystrophy of type 1 (DM1). UV-cross-
linking assays showed that DGCR8 binds weakly to RNAs con-
taining 20 or 100 CUG repeats, compared to an RNA containing
100 CGG repeats (Figure S2G). Similarly, both DROSHA and
DGCR8 from mouse brain extract were captured by RNA affinity
columns composed of expanded CGG repeats, yet neither was
recruited by expanded CUG repeats (Figure S2H). Finally, RNA
FISH coupled to IF demonstrated that both endogenous
DROSHA and DGCR8 were recruited within CGG RNA repeat
aggregates that formed in COS7 cells transfected with a plasmid872 Cell Reports 3, 869–880, March 28, 2013 ª2013 The Authorsexpressing 60 CGG repeats (Figures S2I and S2J). In contrast,
DROSHA and DGCR8 were not recruited within RNA aggregates
of similarly transfected cells expressing either expanded CUG or
AUUCU repeats, which are involved in DM1 and spinocerebellar
ataxia of type 10 (SCA10), respectively (Figures S2I and S2J).
Identical results were obtained in neuronal PC12 or GT17 cells
(data not shown). These results indicate that DGCR8 binds pref-
erentially expanded CGG repeats compared to CUG repeats,
which is consistent with the enhanced stability of the double-
stranded helical structure formed by expanded CGG repeats
compared to CUG repeats (Mooers et al., 2005; Sobczak et al.,
2003; Zumwalt et al., 2007; Kiliszek et al., 2009, 2011; Kumar
et al., 2011). Alternatively, the presence of U:U mismatches
versus noncanonical G:G base pairing, or other structural differ-
ences that are significant, between CUG and CGG hairpins, may
impair the binding of DGCR8. Overall, these results suggest that
DROSHA and DGCR8 are specific components of the CGG RNA
aggregates in FXTAS.
DROSHA Does Not Cleave Expanded CGG Repeats
The binding of DROSHA and DGCR8 to the expanded CGGRNA
repeat raises the possibility that DROSHA may cleave these
repeats into shorter CGG hairpins, which is an attractive hypoth-
esis considering that DICER was reported, in vitro, to partially
process expanded CGG repeats into potentially toxic miRNA-
like CGG RNA repeats (Handa et al., 2003), an observation
also reported for expanded CUG and CAG repeats (Krol et al.,
2007; Ban˜ez-Coronel et al., 2012). Accordingly, we tested
whether DROSHA and DGCR8 can process an RNA containing
60 expanded CGG repeats. However, no cleavage products
were observed, although DROSHA correctly processed a control
pri-miR-125 (Figure S3A). Furthermore, we found no trace of
small miRNA-like CGG RNA after massive parallel sequencing
of RNA extracted from cells transfected with a plasmid express-
ing 60 CGG repeats (data not shown).We propose that structural
differences between pri-miRNAs and CGG expanded repeats,
such as noncanonical G:G base pairing, impair the cleavage
activity of DROSHA. Overall, the recruitment of DROSHA and
DGCR8, without the processing of CGG repeats and the subse-
quent release of the proteins, suggests that the aggregates of
CGG repeats may act as molecular sink, titrating DROSHA and
DGCR8 away from their normal functions.
DROSHA and DGCR8 Are Partially Sequestered by
Expanded CGG Repeats
To test a potential sequestration of DROSHA and DGCR8, we
first analyzed the effect of expanded CGG repeats on the
RNA-binding activity of DGCR8. Gel shift experiments demon-
strated that addition of increasing amounts of unlabeled
expanded CGG RNA repeat progressively competed with the
binding of recombinant purified DGCR8 to radioactively labeled
pri-miR-125 (Figure 3A). As a control, addition of unlabeled
expanded CUG repeats had little or no effect. We confirmed
these results by UV-crosslinking assays, which demonstrated
that addition of increasing amounts of expanded CGG repeats
competed with the binding of DGCR8 to radioactively labeled
pri-miR-124 and pri-miR-125, whereas expanded CUG repeats
had no effects (Figure S3B). Next, we tested the effect of
expanded CGG repeats on the processing activity of DROSHA.
COS7 cells were cotransfected with a plasmid expressing an
ectopic pri-miRNA under the expression of a CMV promoter,
allowing the detection of the primary, precursor, and mature
miRNAs by northern blotting (Figure 3B). Importantly, coexpres-
sion of increasing amounts of expanded CGG repeats reduced
the processing of ectopic pri-miR-124 into pre-miR-124. This
inhibition is specific because expression of control expanded
CUG repeats had no effect on the biogenesis of pri-miR-124
(Figure 3B). We confirmed these results using ectopically ex-
pressed pri-miR-206, pri-miR-146, and pri-miR-26 and found
that expression of expanded CGG repeats inhibited the
DROSHA cleavage of pri-miRNA transcripts into pre-miRNAs
(Figure S3C). As a control, expression of expanded CUG repeats
had no or little effects on miRNA biogenesis (Figure S3D). These
results suggest that expanded CGG repeats compete with the
binding of DGCR8 to pri-miRNAs, reducing the quantity of free
DROSHA and DGCR8 available to process pri-miRNAs, which
leads to reduced processing of pri-miRNAs into pre-miRNAs.
Theoretically, the titration of free DROSHA and DGCR8 may
result in reduced formation of mature miRNAs. To test this
hypothesis, we quantified the expression of endogenous mature
miRNAs upon expression of expanded CGG repeats in neuronal
GT17 cells. Microarray profiling demonstrated that most of the
miRNAs, which presented a modified expression, were reduced
upon transfection of a plasmid expressing 60 CGG repeats (Fig-
ure 3C). Decreased levels of mature miRNAs were confirmed by
quantitative real-time RT-PCR (Figure 3D). The limited number
(56) of miRNAs presenting an expression change, as well as
the limited decrease (20%–50%) of miRNA levels, are consis-
tent with a progressive titration of DROSHA and DGCR8 and
with the early time point (24 hr after transfection) chosen for anal-
ysis. Also, we noted that the expression of a minority of miRNAs
was upregulated upon expression of expanded CGG repeats.
However, a similar upregulation occurred at early time point
(24 hr after transfection) in neuronal GT17 or COS7 cells depleted
of DGCR8 by siRNA, suggesting the existence of rescue mech-
anisms to transiently increase the expression of somemiRNAs in
response to DGCR8 reduction (Figures S3E and S3F).
Importantly, a decrease in miRNA expression could be
triggered by a specific alteration of the miRNA-processing
machinery but may also reflect a global alteration of RNA tran-
scription due to reduced cell viability. To discriminate between
these two hypotheses, we quantified the levels of the primary
transcripts hosting the decreased miRNAs. Quantitative RT-
PCR demonstrated that, whereas mature miRNAs presented
reduced levels, expression of their corresponding pri-miRNAs
was not altered or, even, increased (Figure 3E). Similarly, the
expression of various mRNAs containing pri-miRNAs within their
introns was not altered (Figure 3F). Comparable decrease of
mature miRNA levels with no alterations of the expression of
their corresponding pri-miRNAs was observed in a second cell
model: COS7 cells expressing 60 CGG repeats (Figures S3G
and S3H). These results demonstrate that expanded CGG
repeats alter specifically the processing of pri-miRNAs, without
affecting their transcription. As a further control, we tested the
expression of mirtrons, which are miRNAs processed by the
splicing machinery, thus independent of the processing byDROSHA (Okamura et al., 2007; Ruby et al., 2007). Quantitative
RT-PCR analysis of mirtron-877, mirtron-1224, mirtron-1225,
and mirtron-1226 levels in neuronal GT17 cells expressing
expanded CGG repeats demonstrated that their expression
was not altered (Figure 3G). Similarly, mirtron expression was
not altered in COS7 cells expressing expanded CGG repeats
(Figure S3I). Also, the mRNA and protein expression levels of
DROSHA and DGCR8were normal in cells expressing expanded
CGG repeats, indicating that pathogenic CGG repeats affect the
activity, but not the expression, of DROSHA andDGCR8 (Figures
S3J and S3K). Finally, the transfection of a plasmid encoding
DGCR8 in neuronal cells expressing expanded CGG repeats
rescued the decreased expression of miRNAs, whereas expres-
sion of an inactive form of DGCR8, which was deleted for its
double-stranded RNA-binding domains, presented no rescue
activity (Figure 3H). Overall, these data suggest that expanded
CGG repeats specifically reduced the activity of DROSHA and
DGCR8, without affecting other mechanisms such as general
transcription.
The Processing ofmiRNAs Is Altered in Brain Samples of
Patients with FXTAS
The altered processing of miRNAs in cells overexpressing
expanded CGG repeats raises the question whether a similar
alteration occurs in patients with FXTAS. Microarray analysis of
cerebellar samples from patients with FXTAS revealed that
mis-regulation of miRNAs involved predominantly decreased
expression compared to age-matched controls (Figure 4A).
Quantitative RT-PCR analysis confirmed reduced quantities of
various mature miRNAs in patients with FXTAS relative to
controls (Figure 4B). Note that the expression of mature miRNAs
was not fully abolished but decreased by 20%–50%, indicating
a partial titration of DROSHA and DGCR8 by the expanded
CGG repeats. In contrast, the quantity of mirtron-877, whose
biogenesis depends on the splicing machinery and bypasses
DROSHA, was normal in FXTAS brain samples (Figure 4B). As
a control, quantification of the primary transcripts hosting the
downregulated mature miRNAs demonstrated no changes or
increased expression in patients with FXTAS (Figure 4C). We
confirmed these results in frontal cortex samples of patients
with FXTAS compared to age-matched controls. Quantitative
RT-PCR confirmed that expression of mature miRNAs was
decreased in patients with FXTAS (Figure 4D). Consistent with
a specific alteration of the activity of DROSHA, the quantities
of their corresponding pri-miRNAs were normal or increased in
FXTAS samples compared to age-matched control samples
(Figure 4E). As further controls, expressions of various mirtrons,
whose biogenesis is independent of DROSHA, were normal in
patients with FXTAS (Figure 4F). Overall, these results suggest
that transcription and splicing of pri-miRNAs are not globally
altered in patients with FXTAS but that their processing by
DROSHA is reduced.
Overexpression of DGCR8 Rescues Neuronal Cell Death
A model of titration of DGCR8 by expanded CGG repeats
in patients with FXTAS predicts that depletion of DGCR8
would enhance any phenotype caused by expanded CGG
repeats. To test that hypothesis, we took advantage ofCell Reports 3, 869–880, March 28, 2013 ª2013 The Authors 873
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Figure 3. DROSHA and DGCR8 Activities Are Reduced in CGG-Expressing Cells
(A) Gel shift assays of recombinant His-DGCR8D binding with 100 nM (30,000 cpm) of uniformly a-[32P]CTP internally labeled in-vitro-transcribed pri-miR-125 in
presence of increasing amounts of nonlabeled in-vitro-transcribed RNA containing either 60 CGG repeats or 100 CUG repeats.
(B) A total of 20 mg of total RNA extracted from COS7 cells cotransfected with a pri-miR-124-2 minigene and increasing amounts of a plasmid expressing either
60 CGG or 200 CUG repeats were analyzed by northern blotting using a miR-124 g-[32P]ATP-labeled antisense probe. The mean of at least three independent
transfections is depicted as the percentage of pri-, pre-, and mature miR-124-2. Error bars indicate SD.
(C) Microarray profiling of mature miRNAs expressed in GFP-positive FACS-isolatedGT17 neuronal cells cotransfectedwith a plasmid expressing GFP and either
a plasmid expressing no repeats (n = 3) or 60 CGG repeats (CGG, n = 3). Ordinate is in Log2 scale.
(D–G) Quantitative RT-PCR analysis of the expression of mature (D), pri-miRNAs (E), mRNAs (F), andmirtrons (G) relative to the U6 snRNA or to theRPLPOmRNA
in GFP-positive FACS-isolated GT17 neuronal cells cotransfected with a plasmid expressing GFP and either a plasmid expressing no repeats (n = 3) or a plasmid
(legend continued on next page)
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Figure 4. miRNA Levels Are Reduced in FXTAS Brain Samples
(A) Microarray profiling of mature miRNAs expressed in cerebellum samples of FXTAS and age-matched control patients.
(B and C) Quantitative RT-PCR analysis of the expression of mature (B) and pri-miRNAs (C) relative to the U6 snRNA in cerebellum samples of FXTAS (n = 13) and
age-matched control (n = 4) patients.
(D–F) Quantitative RT-PCR analysis of the expression of mature (D), pri-miRNAs (E), and mirtrons (F) relative to the U6 snRNA in frontal cortex samples of FXTAS
(n = 3) and age-matched control (n = 2) patients. Error bars indicate SD.the neurodegenerative phenotype observed in transgenic
Drosophila melanogaster expressing 90 CGG repeats (Jin
et al., 2003). As previously described, expression of 90 CGG
repeats decreases adult Drosophila viability (Figure S4A).
Interestingly, decreased expression of Pasha (the Drosophila
homolog of DGCR8) by RNAi in CGG transgenic flies resulted
in enhanced early lethality (Figure S4A). A similar aggravated
phenotype was observed with Drosha RNAi lines (Figure S4B).
In contrast, overexpression of Drosha or Pasha in CGG flies
had little or no effect and did not rescue fly lethality (data not
shown). These data suggest that several pathological mecha-
nisms may coexist in the fly model of FXTAS, a model consistent
with the observation of cytoplasmic inclusions containing PURa
in Drosophila (Jin et al., 2007), but not in human cells (Sellier
et al., 2010). Accordingly, we tested mammalian neuronal cells,
in which expression of expanded CGG repeats leads to forma-
tion of CGG RNA nuclear aggregates without formation of
PURa-positive cytoplasmic aggregates. Organotypic cultures
of E18 mouse cortex neurons were transfected at 7 days
in vitro (DIV) with a plasmid expressing 60 CGG repeats andexpressing 60 CGG repeats (CGG, n = 3). DLEU2 is the host gene of pri-miR-16-
TLN2 of pri-miR-190. Error bars indicate SD.
(H) Quantitative RT-PCR analysis of the expression of mature miRNAs relative to
with a plasmid expressing GFP, a plasmid expressing 60 CGG repeats, and ei
DGCR8, deleted for its double-stranded RRM. Error bars indicate SD.
***p < 0.001; **p < 0.01; *p < 0.1.
See also Figure S3.a plasmid expressing the GFP marker for 1 day (8 DIV). As
reported previously by Chen et al. (2010), expression of
expanded CGG repeats resulted in shorter dendrites and an
40% decrease in dendritic branchpoints (Figures 5A and 5B).
As a control, expression of expanded CUG repeats had no
or little effect on neuronal dendritic complexity, indicating a
specific deleterious effect of the expanded CGG repeats (Fig-
ure 5B). Importantly, the sole expression of a plasmid expressing
DGCR8 restored normal dendritic growth and branching in neu-
rons expressing the expandedCGG repeats (Figures 5A and 5B).
In contrast, expression of an inactive form of DGCR8, which was
deleted for its double-stranded RNA-binding domains, pre-
sented no rescue activity (Figure 5B). Similarly, expression of
a control plasmid expressing MBNL1 had no significant effect
anddid not alleviate the dendritic alterations, indicating a specific
role for DGCR8 (Figure 5B). We also tried to rescue the neuronal
cell death induced by expression of expanded CGG RNA
repeats by transfecting either miR-124, miR-9 or miR-125, which
are important miRNAs for neuronal cell function, but we failed to
observe a full rescue, suggesting that more than one miRNA is1, CTDSPL of pri-miR-26a1, ABLIM2 of pri-miR-95, SKA2 of pri-miR-454, and
U6 snRNAs in GFP-positive FACS-isolated GT17 neuronal cells cotransfected
ther a vector expressing Flag-tagged wild-type (WT) DGCR8 or mutant (mut)
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Figure 5. DGCR8 Is Sufficient to Rescue
Expanded CGG Toxicity
(A) Primary cultures of cortex neurons from
E18 mouse embryos were cotransfected with
a plasmid expressing GFP, a vector expressing
either no or 60 CGG repeats, and a plasmid ex-
pressing either a Flag-tagged wild-type DGCR8 or
a mutant Flag-DGCR8 deleted for its double-
stranded RRM. Neurons were analyzed 24 hr
after transfection by RNA FISH using a CCG8x-Cy3
DNA probe coupled to IF using an antibody
directed against the FLAG tag. Magnification,
3603. Magnification of the insets, 2,5003. Scale
bars, 20 mm.
(B) Quantification of the number of dendritic
branchpoints of individual neurons transfected as
in (A). Error bars indicate SD.
(C) Cell viability (tetrazolium) assay of neuronal
GT17 cells transfected for 24 hr with a plasmid
expressing either 200 CUG repeats or 20, 40, or
60 CGG repeats alone, or 60 CGG repeats plus
a plasmid expressing either GFP-SAM68, Flag-
DICER, Flag-DROSHA or Flag-DGCR8. Error bars
indicate SD.
***p < 0.001; **p < 0.01.
See also Figure S4.probably necessary to restore normal neuronal functions. Next,
we tested whether DGCR8 can also rescue the neuronal cell
death caused by expressing expanded CGG repeats. Transfec-
tion of a plasmid expressing 60 CGG repeats in neuronal GT17
cells resulted in a 50% decrease of the cell viability, whereas
expression of either expanded CUG repeats or 20–40 control
CGG repeats was not toxic (Figure 5C). Importantly, the overex-
pression of DGCR8 alone or of DGCR8 plus DROSHA alleviated
the cell death due to the expanded CGG repeats (Figure 5C). As
a control, transfection of control plasmids expressing either
DROSHA alone, DICER or SAM68 had no or little effect. Similar
results were obtained in COS7 cells (Figure S4C). Overall, these
results suggest that a reduced quantity of free DROSHA and
DGCR8 is the principal cause of the decreased dendritic com-
plexity and reduced cell viability observed in neuronal cells ex-
pressing pathogenic-expanded CGG repeats.
DISCUSSION
Our results suggest a model for the cellular dysfunction induced
by the expanded CGG repeats present within the 50 UTR of the
FMR1 mRNA. Expanded CGG repeats form a double-stranded
RNA hairpin (Sobczak et al., 2003; Zumwalt et al., 2007; Kumar876 Cell Reports 3, 869–880, March 28, 2013 ª2013 The Authorset al., 2011; Kiliszek et al., 2011), which
mimics the structure of pri-miRNAs
recognized by DGCR8 (Zeng and Cullen,
2005; Han et al., 2006). We propose that
DGCR8 interacts with the expanded
pathogenic CGG repeats located within
the 50 UTR of the FMR1 mRNA, thus
sequestering itself and its partner,
DROSHA (Figure 6). As a consequence,the level of free DROSHA-DGCR8 microprocessor is decreased,
reducing the expression of mature miRNAs and ultimately result-
ing in neuronal cell dysfunction and degeneration. In that aspect,
our work is reminiscent of the abnormal miRNA biogenesis
and phenotypic abnormalities caused by the genetic haploinsuf-
ficiency of Dgcr8 in the 22q11-deletion mouse model (Stark
et al., 2008; Fe´nelon et al., 2011; Schofield et al., 2011).
A DROSHA-DGCR8 titration model has several predicted
consequences for FXTAS pathology. First, a model based on
DGCR8 titration predicts that the expansion of CGG repeats
must exceed a minimal threshold size to accommodate DGCR8
binding (Zeng and Cullen, 2005; Han et al., 2006). This is con-
sistent with the CGG repeat dependence of clinical involve-
ment and degree of severity observed in patients with FXTAS
(Tassone et al., 2007; Hoem et al., 2011), in whom it is estimated
that ‘‘normal’’ CGG polymorphic repeat lengths are below 40
repeats, ‘‘gray zone’’ alleles contain 40–55 repeats, and patients
with FXTAS are defined by premutation alleles containing 55–
200 CGG repeats. Second, we observed that miRNA expression
was decreased but not fully abolished, which is consistent with
a partial and progressive sequestration of DROSHA-DGCR8
and, consequently, a progressive worsening of the disease
symptoms. Third, previous studies have identified various
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Figure 6. Model of DROSHA and DGCR8 Titration by Expanded CGG
Repeats
Expanded CGG repeats fold into a double-stranded RNA hairpin that recruits
DGCR8, resulting in the titration and immobilization of DROSHA and DGCR8.
The reduced levels of free DROSHA and DGCR8 available to normally process
pri-miRNAs into pre-miRNAs result in reduced levels of mature miRNAs, and
ultimately, in neuronal cell dysfunctions.proteins (e.g., PURa, hnRNP A2/B1, SAM68, etc.) as candidates
for transduction of the CGG-expanded repeat toxicity (Iwahashi
et al., 2006; Jin et al., 2007; Sofola et al., 2007; Sellier et al.,
2010). However, the presence of cytoplasmic inclusions recruit-
ing PURa in fly, but not in mammalian neuronal cells expressing
expanded CGG repeats, raises the question of the superimposi-
tion of two different pathological mechanisms in Drosophila: one
involving PURa in cytoplasmic inclusions, and another involv-
ing the sequestration of specific RNA-binding protein(s) by
the expanded CGG repeats within nuclear aggregates. Such
superimposition of pathogenic mechanisms may explain why
overexpression of Pasha has no evident rescue effect in CGG-
transgenic Drosophila, whereas expression of DGCR8 rescues
the toxicity induced by expression of expanded CGG repeats in
primary cultures of mouse neurons. Also, this superimposition
model would explain the presence of ubiquitin-positive aggre-
gates that donot colocalizewithCGGRNAaggregates in knockin
mouse models expressing expanded CGG repeats, as well as
the recent report that only a subset of miRNAs is mis-regulated
in Drosophila expressing expanded CGG repeats (Tan et al.,
2012). Whether such a superimposition of pathological mecha-
nisms also exists in patients with FXTAS remains an open ques-
tion, yet to be determined. Finally, we found previously that
SAM68 is sequestered within CGG RNA aggregates and that
SAM68 rescues some of the splicing alterations observed in
CGG-expressing cells (Sellier et al., 2010). However, we now
show that the sequestration of SAM68 into CGG RNA aggre-
gates requires DGCR8 and that restoration of SAM68 function
is not sufficient to recover all normal neuronal cell functions. Bycontrast, expression of DGCR8 alone is sufficient to restore to
normal both the dendritic morphological abnormalities and the
loss of neuronal viability induced by expression of pathogenic-
expanded CGG repeats in cultured mouse neurons.
In conclusion, this work raises the possibility that other human
diseases could operate through a similar sequestration mecha-
nism, provided that themutant RNA forms a secondary structure
that is recognized by the double-stranded RNA-binding protein,
DGCR8.An appealing hypothesis in light of the recent finding that
noncoding RNAs exceed coding transcripts by more than 5-fold
and that an increasing number of potentially structured G-rich
expanded repeats are found associated with pathologies, such
as the expanded CCGGGG repeats in the C9ORF72 gene that
cause ALS-FTD (DeJesus-Hernandez et al., 2011). The current
observations should also facilitate the development of novel
model systems to better understand the molecular and cellular
mechanisms underlying FXTAS. Finally, from the perspective of
FXTAS treatment, identification of a key interaction between
DGCR8 and the expanded CGG repeats represents an attractive
target for therapeutic intervention. Indeed, if DROSHA and
DGCR8 are sequestered, they are nevertheless present and
potentially functional; hence, a strategy based on CGG-anti-
sense oligonucleotides or pharmacological compounds (Disney
et al., 2012) able to release the trapped DGCR8 would presum-
ably return to normal the expression ofmiRNAs altered in FXTAS.
EXPERIMENTAL PROCEDURES
Nano-LC-MS/MS Analysis
Nuclear extract was prepared frommouse brain as described by Dignam et al.
(1983). A total of 300 mg of nuclear extract was passed over an in-vitro-tran-
scribed and -biotinylated RNA (Biotin 11 CTP; PerkinElmer) bound to strepta-
vidin-coated magnetic beads (Dynabeads M-280 streptavidin; Invitrogen) in
the presence of 20 mM HEPES, 300 mM NaCl, 8 mM MgCl2, 0.01% NP40,
1 mM DTT, and protease inhibitor (PIC; Roche). The magnetic beads with
immobilized RNA and its bound proteins were washed three times with the
binding buffer, and bound proteins were eluted by boiling 3 min in the
sample buffer prior to 4%–12% SDS-PAGE (NuPAGE 4%–12% bis-Tris Gel;
Invitrogen) separation and silver staining (SilverQuest; Invitrogen). The protein
bands were excised, digested, and identified using NanoESI_Ion Trap (LTQ
XL; Thermo Fisher Scientific).
Cell Cultures and Transfections
Primary cortical neurons were prepared from C57Bl/6 mouse embryos at E18
and grown on polylysine-coated 24-well plates in neurobasal medium (NBM)
supplemented with 13B27, 0.5 mM L-glutamine, and 100 IU/ml penicillin/
streptomycin at 37C with 5% CO2. Neurons were transfected at day 7 with
Lipofectamine 2000 (Invitrogen) in 400 ml NBM. Medium was replaced after
3 hr with a 1:1 (v:v) mixture of conditioned and fresh NBM. After 30 hr, the
neurons were fixed for FISH/ IF. COS7 cells were cultured in Dulbecco’s
modified Eagle’s medium (DMEM), 10% fetal bovine serum, and gentamicin
at 37C in 5% CO2. PC12 cells were cultured in DMEM, 10% horse serum,
5% fetal calf serum, and penicillin at 37C, 5% CO2. GT17 cells were grown
in 10% fetal bovine serum, gentamicin, and penicillin at 37C in 5% CO2 and
transfected 24 hr after plating in DMEM and 0.1% fetal bovine serum to block
cell divisions, using either FuGENE HD (Roche) for COS7 cells or Lipofect-
amine 2000 for PC12 or GT17 cells. For RNA FISH/IF, GT17 cells were plated
in 24-well plates on glass coverslips precoated with a solution of 1% collagen
type I (BD Biosciences).
RNA FISH Combined with IF
Patients with FXTAS have been described previously (case 6, 7, and 9 of
Greco et al., 2006). Mouse or human brain sections were deparaffinizedCell Reports 3, 869–880, March 28, 2013 ª2013 The Authors 877
two times for 20 min in Histosol Plus (Shandon) and dehydrated as follows:
twice in ethanol 100% (5 min), twice in ethanol 95% (5 min), once in ethanol
80% (5 min), once in ethanol 70% (5 min), and rinsed in PBS before RNA
FISH. Glass coverslips containing plated cells or brain sections treated as
described above were fixed in cold acetone during 20 min at 20C and
washed three times with PBS. The coverslips or slides were incubated for
10 min in PBS plus 0.5% Triton X-100 and washed three times with
PBS before prehybridization in 40% DMSO, 40% formamide, 10% BSA
(10 mg/ml), 23 SCC for 30 min. The coverslips or slides were hybridized
for 2 hr in 40% formamide, 10% DMSO, 23 SCC, 2 mM vanadyl ribonucle-
oside, 60 mg/ml tRNA, and 30 mg/ml BSA plus 0.75 mg (CCG)83-Cy3 DNA
oligonucleotide probe (Sigma-Aldrich). The coverslips or slides were washed
twice in 23 SCC/50% formamide and twice in 23 SCC. Following FISH, the
coverslips or slides were washed twice successively in 23 SCC/50% form-
amide, in 23 SCC, and in PBS. The coverslips or slides were incubated 2 hr
with primary antibody against Drosha (1:100 dilution, AB12286; Abcam) or
DGCR8 (1:100 dilution, HPA019965; Sigma-Aldrich). Slides or coverslips
were washed twice with PBS before incubation with a goat anti-rabbit
secondary antibody conjugated with Alexa Fluor 488 (1:500 dilution; Thermo
Fisher Scientific) for 60 min, incubated for 10 min in 23 SCC/DAPI (1:10,000
dilution), and rinsed twice in 2 3 SSC before mounting in Pro-Long media
(Molecular Probes). Slides were examined using a fluorescence microscope
(Leica), and identical exposure or microscope setting was used for control or
FXTAS brain section analyses.
Quantitative Real-Time PCR
Total RNA from cells or patient brains, the latter obtained under approved IRB
protocols (University of California, Davis), was isolated by TriReagent (Molec-
ular Research Center). cDNAs were generated using the miScript II RT Kit
(QIAGEN) for quantification of miRNAs or the Transcriptor High Fidelity
cDNA Synthesis Kit (Roche Diagnostics) for quantification of mRNAs. qPCR
of miRNAs was realized using the miScript Primer Assay (QIAGEN) and
miScript Sybr Green PCR Kit (QIAGEN) in a LightCycler 480 (Roche) with
15 min at 94C followed by 50 cycles of 15 s at 94C, 20 s at 55C, and 20 s
at 72C. U6 snRNAwas used as standard. qPCR of mRNAs was realized using
the LightCycler 480 SYBR Green I Master (Roche) in a LightCycler 480 with
15 min at 94C followed by 50 cycles of 15 s at 94C, 20 s at 58C, and 20 s
at 72C. The primers are listed in Table S1. RPLPO mRNA was used as stan-
dard, and data were analyzed using the LightCycler 480 analysis software
(2DCt method).
For additional details, please see the Extended Experimental Procedures.
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